Mr Davies completed the majority of his orthopaedic surgical training in the Oxford region where he also undertook his DPhil looking at the use of mesenchymal stem cells in cartilage regeneration. He completed his training and continued to pursue his research interests in the department as part of an NIHR Clinical Lectureship. His main research interests are in the use of cell-based therapies for the repair of musculoskeletal tissue and the development and utilisation of large dataset to facilitate research.
Bottle A, Griffiths R, White S, Wynn-Jones H, Aylin P, Moppett I, Chowdhury E, Wilson H, Davies BM. Periprosthetic fractures – the next fragility fracture epidemic? A national observational study. BMJ Open. 2020 10:e042371.
Davies BM, Snelling SJ, Quek L, Hakimi O, Ye H, Carr AJ, Price AJ.(2016) Identifying the optimum source of mesenchymal stem cells for use in knee surgery. J Orthop Res. Dec 9.
Arshad Z, Karmen L, Choudhary R, Smith JA, Branford OA, Brindley DA, Pettitt D, Davies BM.(2016) Cell assisted lipotransfer in breast augmentation and reconstruction: A systematic review of safety, efficacy, use of patient reported outcomes and study quality. JPRAS Open.Dec; 10:5–20.
Davies BM, Rikabi S, French A, Pinedo-Villanueva R, Morrey ME, Wartolowska K, Judge A, MacLaren RE, Mathur A, Williams DJ, Wall I, Birchall M, Reeve BC, Atala A, Barker RW, Cui Z, Furniss D, Bure K, Snyder EY, Karp JM, Price AJ, Carr AJ, Brindley DA. (2014) Quantitative assessment of barriers to the clinical development and adoption of cellular therapies: A pilot study. J Tissue Eng. 5(0):2041731414551764
Davies BM, Morrey ME, Mouthuy P-A, Baboldashti NZ, Hakimi O, Snelling S, Price AJ, Carr AJ.(2013) Repairing damaged tendon and muscle: are mesenchymal stem cells and scaffolds the answer? Regen Med. Sep; 8(5):613–30.